AMGN

Amgen
D

AMGN

283.72
USD
-12.22
(-4.13%)
Market Closed
Volume
249,350
EPS
0
Div Yield
0
P/E
49
Market Cap
152,451,046,298
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    165.02 USD
    B
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    154.02 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    96.29 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    24.8 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    More
News

Title: Amgen

Sector: Healthcare
Industry: Drug Manufacturers - General
Amgen Inc. is an American global biopharmaceutical company that engages in the development, manufacture and marketing of human therapeutics. It is headquartered in Thousand Oaks, California. The company has deep interests in molecular biology and biochemistry, which underpin its goal to provide human care based on recombinant DNA technology. Some of the company’s best-performing products include Neulasta and Enbrel. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980.